Counterweight Ventures’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.18M | Buy |
9,315
+272
| +3% | +$34.4K | 0.77% | 42 |
|
2025
Q1 | $1.16M | Buy |
9,043
+451
| +5% | +$57.7K | 0.83% | 43 |
|
2024
Q4 | $1.14M | Buy |
8,592
+138
| +2% | +$18.2K | 0.8% | 43 |
|
2024
Q3 | $1.23M | Buy |
8,454
+2,693
| +47% | +$392K | 0.87% | 41 |
|
2024
Q2 | $791K | Buy |
5,761
+245
| +4% | +$33.6K | 0.6% | 44 |
|
2024
Q1 | $757K | Sell |
5,516
-540
| -9% | -$74.1K | 0.61% | 44 |
|
2023
Q4 | $823K | Buy |
+6,056
| New | +$823K | 0.75% | 41 |
|